Publications by authors named "C Freycon"

Claim this Profile
N
Neoantigenic properties of TP53 variants influence cancer risk in individuals with Li-Fraumeni syndrome.
Emilie Montellier, Olivier Manches, Jonathan Gaucher, Claire Freycon, David Hoyos

EBioMedicine· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life Priorities of Childhood Acute Lymphoblastic Leukemia Survivors Enrolled in EORTC Studies, and a Comparison of Instruments.
Jammbe Musoro, Charlotte Sleurs, Ali Rowsell, Stefan Suciu, Michal Kicinski, Claire Freycon

Pediatr Blood Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized screening strategies for R337H carriers: a retrospective cohort study of tumor spectrum in Li-Fraumeni syndrome adult carriers.
Pedro A F Galante, Gabriela D A Guardia, Janina Pisani, Renata L Sandoval, Mateus C Barros-Filho, Claire Freycon

Lancet Reg Health Am· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clustering of variants into functional classes correlates with cancer risk and identifies different phenotypes of Li-Fraumeni syndrome.
Emilie Montellier, Nathanaël Lemonnier, Judith Penkert, Claire Freycon, Sandrine Blanchet

iScience· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of the prospective EORTC Children Leukemia Group study 58081 in precursor B- and T-cell acute lymphoblastic leukemia.
Carine Domenech, Michal Kicinski, Barbara De Moerloose, Caroline Piette, Wadih A Chahla, Claire Freycon

Hemasphere· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis